Cholecystitis in Villavicencio Hospitals
Launched by HOSPITAL DEPARTAMENTAL DE VILLAVICENCIO · Sep 16, 2023
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how patients with cholecystitis, a condition that causes inflammation of the gallbladder, are treated at hospitals in Villavicencio. The goal is to gather information about how often patients are discharged from the hospital due to this condition, the types of surgeries they undergo, any complications that arise, and the overall outcomes of their treatments. By analyzing hospital records from 2019 to 2022, researchers hope to find ways to improve care for patients with biliary tract diseases.
If you or a family member have been admitted to the hospital with acute or chronic biliary issues, you may be eligible to participate in this study. There are no specific exclusions, so if you're receiving treatment for these conditions, your information could contribute to understanding and improving patient care in the region. The findings from this study could help hospitals provide better and more timely treatment for patients with cholecystitis in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients admitted with acute or chronic biliary pathology.
- Exclusion Criteria:
- • None.
About Hospital Departamental De Villavicencio
The Hospital Departamental de Villavicencio is a leading healthcare institution dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. With a commitment to excellence in patient care, the hospital plays a pivotal role in the development of new therapies and treatment protocols. By fostering collaboration among healthcare professionals, researchers, and regulatory bodies, the hospital aims to contribute to the scientific community while ensuring the highest standards of safety and ethical practices in clinical research. Its diverse patient population and state-of-the-art facilities make it an ideal setting for conducting impactful clinical studies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Villavicencio, Meta, Colombia
Villavicencio, Meta, Colombia
Patients applied
Trial Officials
Norton Perez, MD
Principal Investigator
Cooperative University of Colombia
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported